MedTrace Logo

Treatment Outcomes of Esophageal Cancer

NCT05177393 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2476

Last updated 2024-09-19

No results posted yet for this study

Summary

This study will be a carried out through a prospective observational cohort design in conjunction with researchers in the African Esophageal Cancer Consortium (AfrECC). The purpose of this research is to prospectively evaluate outcomes related to existing treatment strategies for esophageal cancer (EC) at participating sites within AfrECC.

Conditions

  • Esophageal Cancer

Interventions

OTHER

Assessment of patient-reported outcomes (PROs)

Questionnaires will be administered to participants

Sponsors & Collaborators

  • Westat

    collaborator OTHER

  • African Esophageal Cancer Consortium (AfrECC)

    collaborator UNKNOWN

  • National Cancer Institute (NCI)

    collaborator NIH

  • Celgene Corporation

    collaborator INDUSTRY

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Geoffrey Buckle, MD, MPH · University of California, San Francisco

  • Katherine Van Loon, MD, MPH · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Kenya
  • Malawi
  • Tanzania

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05177393 on ClinicalTrials.gov